Cargando…
Tumour sampling method can significantly influence gene expression profiles derived from neoadjuvant window studies
Patient-matched transcriptomic studies using tumour samples before and after treatment allow inter-patient heterogeneity to be controlled, but tend not to include an untreated comparison. Here, Illumina BeadArray technology was used to measure dynamic changes in gene expression from thirty-seven pai...
Autores principales: | Pearce, Dominic A., Arthur, Laura M., Turnbull, Arran K., Renshaw, Lorna, Sabine, Vicky S., Thomas, Jeremy S., Bartlett, John M. S., Dixon, J. Michael, Sims, Andrew H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935948/ https://www.ncbi.nlm.nih.gov/pubmed/27384960 http://dx.doi.org/10.1038/srep29434 |
Ejemplares similares
-
Molecular changes during extended neoadjuvant letrozole treatment of breast cancer: distinguishing acquired resistance from dormant tumours
por: Selli, Cigdem, et al.
Publicado: (2019) -
Mondor's disease of the breast: A cutaneous thromboembolic manifestation of Covid-19?
por: Renshaw, Lorna, et al.
Publicado: (2022) -
Direct integration of intensity-level data from Affymetrix and Illumina microarrays improves statistical power for robust reanalysis
por: Turnbull, Arran K, et al.
Publicado: (2012) -
On-treatment biomarkers can improve prediction of response to neoadjuvant chemotherapy in breast cancer
por: Bownes, Richard J., et al.
Publicado: (2019) -
Correcting for intra-experiment variation in Illumina BeadChip data is necessary to generate robust gene-expression profiles
por: Kitchen, Robert R, et al.
Publicado: (2010)